Rhythm control in left ventricular assist device patients: should we consider abandoning amiodarone?

Hellenic J Cardiol. 2018 May-Jun;59(3):186-188. doi: 10.1016/j.hjc.2017.09.005. Epub 2017 Sep 23.

Authors

Chris J Kapelios¹, Michalis Tsamatsoulis², Christos Charitos²

Affiliations

¹ Department of Cardiology, Laiko General Hospital, 17 Agiou Thoma Street, 11 527, Athens, Greece. Electronic address: [email protected].
² Department of Cardiothoracic Surgery, Evangelismos Hospital, 45-47 Ypsilantou Street, 10 676, Athens, Greece.

PMID: 28951195
DOI: 10.1016/j.hjc.2017.09.005

No abstract available

Keywords: amiodarone; drug side-effect; pulmonary infiltrate; pulmonary toxicity.

Publication types

Letter

MeSH terms

Amiodarone* / administration & dosage
Amiodarone* / adverse effects
Cardiomyopathies / complications*
Cardiovascular Agents / administration & dosage
Cardiovascular Agents / adverse effects
Drug-Related Side Effects and Adverse Reactions* / diagnosis
Drug-Related Side Effects and Adverse Reactions* / etiology
Drug-Related Side Effects and Adverse Reactions* / physiopathology
Drug-Related Side Effects and Adverse Reactions* / therapy
Glucocorticoids / administration & dosage*
Heart Failure / diagnosis
Heart Failure / etiology
Heart Failure / therapy
Heart-Assist Devices
Humans
Long Term Adverse Effects / chemically induced
Long Term Adverse Effects / diagnosis
Long Term Adverse Effects / physiopathology
Long Term Adverse Effects / therapy
Lung* / diagnostic imaging
Lung* / drug effects
Male
Middle Aged
Prosthesis Implantation / adverse effects
Prosthesis Implantation / methods
Treatment Outcome
Withholding Treatment

Substances

Cardiovascular Agents
Glucocorticoids
Amiodarone